Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Randy Schmid who wrote (2863)	11/17/1997 3:36:00 PM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

IMS script data for...hmmm not sure if it's for first week of November or last week, but it's the data released today. I'll clarify the week with my broker. New scripts up 3% to 3261 Refills up 7% to 5866 Total up 6% to 9127 sf

To: Randy Schmid who wrote (2863)	11/17/1997 11:12:00 PM
From: Gary L. Kepler	Read Replies (1) \| Respond to of 6136

Thanks Randy for bringing a different perspective.

To: Randy Schmid who wrote (2863)	11/17/1997 11:29:00 PM
From: scaram(o)uche	Respond to of 6136

Randy said "Hi all, back from some extended business trips......." Loaded report. Thanks. AGPH is advertising hot and heavy in the S.F. Chronicle for Director-level positions, facility- and operations-related. They're trying to pick off nuts and bolts from Bay Area biotechs. Rick

To: Randy Schmid who wrote (2863)	11/18/1997 12:11:00 AM
From: John Metcalf	Read Replies (1) \| Respond to of 6136

Randy, thanks for a great report. The large listing of process chemistry jobs on Agouron's webpage, including qualifications of CGMP experience, lead me to believe that Agouron is gearing up to do their own manufacturing. Your report suggests that their inhouse manufacturing is only small batches for trial and experimental use. Are your chemist friends getting ready for commercial manufacturing? Was there discussion of pulling in commercial manufacturing, or does Agouron intend to continue with their vendors?